The management team at Cornell Pharma will leverage a combined 75+ years of experience in pharmaceutical manufacturing and supply chain to build a world-class cGMP-certified manufacturing facility producing life saving therapies, primarily parenteral (LVP). Cornell Pharma’s executive team has worked for the largest global pharmaceutical companies and has operational experience in Africa and North America that spans the entire product lifecycle from idea generation to market entry.
Manufacturing in West Africa will allow Cornell Pharma to have lower operating expenses than competitors while delivering high growth and high-margin therapeutics.
Cornell Pharma will take advantage of the ease of import and export due to ECOWAS (Economic Community of West African States) to become the number one provider of intravenous and anti-infective therapies in West Africa and eventually all of Sub-Saharan Africa.
HUMAN CAPITAL: Highly accomplished management team with over 75 years of pharmaceutical manufacturing experience
World-class management and exceptional strategic advisors in place to maximize value and ensure long-term success
BUSINESS STRATEGY: Patient Centric. We put the patient at the center of strategy and operations and focus on outcomes rather than medicines. We believe this differentiates us from our competitors and brings long term value to our stakeholders.
Growth by acquisition and partnerships. Will take undervalued companies and leverage management experience to grow portfolio, efficiency, and market share.
PRODUCT PIPELINE: Pipeline aligned with market gaps and focused on management team specialty
Quality of development kept to a global standard
Leverage first mover advantage to push less sophisticated products with high margins. Transition to more sophisticated products with profits.
COMPANY CULTURE: Establish a culture of continuous improvement. Everyone is accountable for improving the company to ensure we achieve our mission in the safest and most efficient manner.
Culture will be driven by data. Data will be the lifeblood of our competitive advantage.